Mimi Lifen Quan

This inventor holds 82 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 18 EPO patents, primarily in Factor Inhibitors (CPC class C07D-). Top assignees: Bristol-Myers Squibb Compnay, Bristol-Myers Squibb Pharma Company, Dupont Pharmaceuticals Company. Active years: 1995-2025.

USPTO Granted Patents = 82 (Patent Applications = 5)

% Patents Active = 98.8

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 18 (Patent Applications = 13)

Average Co-Inventor Count = 4.5

ph-index = 20

Forward Citations = 1,352(Granted Patents)

Forward Citations (Not Self Cited) = 1,182(Dec 10, 2025)

Inventors with similar research interests:

🔬 See more inventors

Location History:

Newark, DE (US) (1995 - 2007)
Yardley, PA (US) (2005 - 2021)

Company Filing History:

46 out of 3,736

Bristol-Myers Squibb Compnay

patents

19 out of 234

Bristol-Myers Squibb Pharma Company

patents

9 out of 106

Dupont Pharmaceuticals Company

patents

4. 3 out of 16,339

E.i. Dupont De Nemours and Company

patents

5. 3 out of 206

The Dupont Merck Pharmaceutical Company

patents

6. 1 out of 15

Dupont Pharmaceuticals, Inc.

patents

7. 1 out of 834,411

Other

patents

Years Active: 1995-2025

Loading Chart...

Areas of Expertise:

Factor XIa Inhibitors

Factor Xa Inhibitors

Serine Protease Inhibitors

Macrocycles

Phthalazinones

Tricyclic Derivatives

Five-Membered Heterocycles

Arylpropionamide

Guanidine Mimetics

Diamide Macrocycles

Dipeptide Analogs

Biarylmethyl Indolines

82 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12404274 - Macrocycles as factor xia inhibitors (2025-09-02),

2. 12187699 - GSPT1 compounds and methods of use of the novel compounds (2025-01-07),

3. 11136327 - Macrocycles as factor XIA inhibitors (2021-10-05),

4. 10730858 - Lactam, cyclic urea and carbamate, and triazolone derivatives as potent and selective rock inhibitors (2020-08-04),

5. 10487086 - Macrocycles as factor XIa inhibitors (2019-11-26),

6. 10385026 - Phthalazinones and isoquinolinones as rock inhibitors (2019-08-20),

7. 10112939 - Tied-back benzamide derivatives as potent rock inhibitors (2018-10-30),

8. 10112936 - Five-membered heterocycles useful as serine protease inhibitors (2018-10-30),

9. 10081623 - Diamide macrocycles that are FXIa inhibitors (2018-09-25),

10. 9926282 - Phthalazinones and isoquinolinones as rock inhibitors (2018-03-27),

11. 9914740 - Tricyclic pyrido-carboxamide derivatives as rock inhibitors (2018-03-13),

12. 9828345 - Phenylpyrazole derivatives as potent ROCK1 and ROCK2 inhibitors (2017-11-28),

13. 9802939 - Macrocycles as factor XIa inhibitors (2017-10-31),

14. 9745313 - Macrocycles as factor XIa inhibitors (2017-08-29),

15. 9663529 - Tricyclic pyrido-carboxamide derivatives as rock inhibitors (2017-05-30),

Title: Inventor Mimi Lifen Quan: Revolutionizing Technology in Yardley

Introduction: Mimi Lifen Quan is a pioneering inventor based in Yardley, PA, known for her groundbreaking contributions to the field of technology and innovation.

Latest Patents: Mimi Lifen Quan holds several patents in cutting-edge technologies related to artificial intelligence, renewable energy, and biotechnology, showcasing her versatility and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Mimi Lifen Quan has worked with top research institutions and leading tech companies, consistently pushing the boundaries of what is possible in the realm of innovation.

Collaborations: Throughout her career, Mimi Lifen Quan has collaborated with renowned scientists, engineers, and inventors, fostering a culture of creativity and excellence in all her projects.

Conclusion: Inventor Mimi Lifen Quan's dedication to innovation and her relentless pursuit of technological advancement continue to inspire and shape the future of technology in Yardley and beyond.